These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23453870)

  • 1. Review of epidemiology and management of atrial fibrillation in developing countries.
    Nguyen TN; Hilmer SN; Cumming RG
    Int J Cardiol; 2013 Sep; 167(6):2412-20. PubMed ID: 23453870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population rates of hospitalization for atrial fibrillation/flutter in Canada.
    Humphries KH; Jackevicius C; Gong Y; Svensen L; Cox J; Tu JV; Laupacis A;
    Can J Cardiol; 2004 Jul; 20(9):869-76. PubMed ID: 15266356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry.
    Oldgren J; Healey JS; Ezekowitz M; Commerford P; Avezum A; Pais P; Zhu J; Jansky P; Sigamani A; Morillo CA; Liu L; Damasceno A; Grinvalds A; Nakamya J; Reilly PA; Keltai K; Van Gelder IC; Yusufali AH; Watanabe E; Wallentin L; Connolly SJ; Yusuf S;
    Circulation; 2014 Apr; 129(15):1568-76. PubMed ID: 24463370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of atrial fibrillation.
    Bajpai A; Savelieva I; Camm AJ
    Br Med Bull; 2008; 88(1):75-94. PubMed ID: 19059992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulants in patients with atrial fibrillation and end-stage renal disease.
    Brimble KS; Ingram AJ; Eikelboom JW; Hart RG
    Postgrad Med; 2012 Nov; 124(6):17-25. PubMed ID: 23322135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective investigation of hospitalized patients with atrial fibrillation in mainland China.
    Society of Cardiology, Chinese Medical Association
    Chin Med J (Engl); 2004 Dec; 117(12):1763-7. PubMed ID: 15603701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial fibrillation in chronic hemodialysis patients: prevalence, types, predictors, and treatment practices in Greece.
    Tsagalis G; Bakirtzi N; Manios E; Chouliaras I; Papagiannidou P; Stamellou E; Akrivos T; Makris F; Psimenou E; Koutroubas G; Xinos K; Vemmos K
    Artif Organs; 2011 Oct; 35(10):916-22. PubMed ID: 21615429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?
    Escobar C; Barrios V; Jimenez D
    Cardiovasc Ther; 2010 Oct; 28(5):295-301. PubMed ID: 20718760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic therapies for stroke prevention in atrial fibrillation.
    Economides Muñoz C; Singh BN
    Minerva Cardioangiol; 2004 Apr; 52(2):125-39. PubMed ID: 15194994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting.
    Gurwitz JH; Monette J; Rochon PA; Eckler MA; Avorn J
    Arch Intern Med; 1997 May; 157(9):978-84. PubMed ID: 9140268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atrial fibrillation--epidemiologic, economic and individual burden of disease].
    Brüggenjürgen B; Reinhold T; McBride D; Willich SN
    Dtsch Med Wochenschr; 2010 Mar; 135 Suppl 2():S21-5. PubMed ID: 20221974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of age on treatment, trends and outcome of patients hospitalized with atrial fibrillation: insights from a 20-years registry in a Middle-Eastern country (1991-2010).
    Salam AM; AlBinali HA; Al-Sulaiti EM; Al-Mulla AW; Singh R; Al Suwaidi J
    Aging Clin Exp Res; 2012 Dec; 24(6):682-90. PubMed ID: 23211770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of new drugs for management of atrial fibrillation.
    Hollands JM; Gowan M; Riney JN; Deal EN; Kates AM
    Ann Pharmacother; 2012 Dec; 46(12):1656-70. PubMed ID: 23249869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New treatments for stroke and thromboembolism prevention in atrial fibrillation].
    Shiyovich A; Khalameizer V; Katz A
    Harefuah; 2014 Jan; 153(1):32-8, 64. PubMed ID: 24605405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study).
    Friberg L; Hammar N; Ringh M; Pettersson H; Rosenqvist M
    Eur Heart J; 2006 Aug; 27(16):1954-64. PubMed ID: 16847008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of care for atrial fibrillation among patients hospitalized for heart failure.
    Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC;
    J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin use in nursing home residents: results from the 2004 national nursing home survey.
    Ghaswalla PK; Harpe SE; Slattum PW
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):25-36.e2. PubMed ID: 22226690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of economics and cost-effectiveness analyses of anticoagulant therapy for stroke prevention in atrial fibrillation in the US.
    von Schéele B; Fernandez M; Hogue SL; Kwong WJ
    Ann Pharmacother; 2013 May; 47(5):671-85. PubMed ID: 23606551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.